Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed

NCT00618748 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar I Disorder

Interventions

DRUG: Olanzapine

Sponsor

Eli Lilly and Company